HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukihiro Ohno Selected Research

(5,6-dimethoxyindan-2-yl)dipropylamine

1/2022Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor.
4/2014Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukihiro Ohno Research Topics

Disease

17Seizures (Absence Seizure)
04/2019 - 04/2010
11Epilepsy (Aura)
07/2023 - 11/2010
11Motor Disorders
04/2019 - 07/2008
10Tremor (Tremors)
01/2022 - 01/2015
10Hypokinesia (Bradykinesia)
01/2019 - 07/2008
10Catalepsy
11/2015 - 10/2008
6Cognitive Dysfunction
01/2019 - 10/2007
6Schizophrenia (Dementia Praecox)
07/2017 - 10/2007
5Parkinson Disease (Parkinson's Disease)
06/2018 - 06/2010
4Glioma (Gliomas)
07/2023 - 08/2012
4Autosomal Dominant Lateral Temporal Lobe Epilepsy
07/2023 - 08/2012
4Mood Disorders (Mood Disorder)
04/2018 - 02/2011
4Temporal Lobe Epilepsy
01/2018 - 01/2013
4Dyskinesias (Dyskinesia)
11/2015 - 06/2010
3Essential Tremor (Essential Tremors)
01/2022 - 06/2018
3Basal Ganglia Diseases (Basal Ganglia Disease)
10/2013 - 04/2009
2Dementia (Dementias)
01/2019 - 04/2015
2Focal Cortical Dysplasia
01/2018 - 01/2017
2Type 1 Episodic Ataxia
01/2015 - 01/2012
2Febrile Seizures (Febrile Seizure)
02/2011 - 04/2010
2Acute Kidney Injury (Acute Renal Failure)
12/2009 - 11/2006
2Hypertension (High Blood Pressure)
04/2007 - 12/2006
2Ischemia
11/2006 - 04/2003
1Down Syndrome (Down's Syndrome)
11/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2019

Drug/Important Bio-Agent (IBA)

15Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 10/2007
12Haloperidol (Haldol)FDA LinkGeneric
07/2017 - 07/2008
6Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 02/2011
6Serotonin ReceptorsIBA
06/2017 - 06/2010
5NicotineFDA Link
01/2022 - 11/2016
5Levetiracetam (Keppra)FDA LinkGeneric
06/2018 - 11/2010
5Levodopa (L Dopa)FDA LinkGeneric
06/2018 - 06/2010
5WAY 100135IBA
06/2017 - 07/2008
4Leucine (L-Leucine)FDA Link
07/2023 - 08/2012
4Pentylenetetrazole (Metrazol)IBA
01/2019 - 09/2010
4Ethosuximide (Zarontin)FDA LinkGeneric
06/2018 - 02/2011
4Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
12/2017 - 01/2012
3LigandsIBA
01/2022 - 01/2013
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2020 - 04/2003
3Potassium Channels (Potassium Channel)IBA
11/2020 - 07/2016
3Trihexyphenidyl (Artane)FDA LinkGeneric
04/2019 - 10/2008
3MecamylamineIBA
04/2019 - 11/2016
3Acetylcholine (Acetylcholine Chloride)FDA Link
04/2019 - 11/2016
3Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2013
3Valproic Acid (Depakote)FDA LinkGeneric
06/2018 - 02/2011
3Phenytoin (Dilantin)FDA LinkGeneric
01/2018 - 02/2011
3SB 258585IBA
06/2017 - 02/2011
38-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
06/2017 - 07/2008
3Serotonin 5-HT1 Receptor AgonistsIBA
06/2017 - 10/2013
3AD 6048IBA
11/2015 - 08/2010
3Serotonin (5 Hydroxytryptamine)IBA
01/2013 - 07/2008
2gamma-Aminobutyric Acid (GABA)IBA
07/2023 - 11/2020
2(5,6-dimethoxyindan-2-yl)dipropylamineIBA
01/2022 - 04/2014
2aspartoacylaseIBA
11/2020 - 07/2016
2N-Methylaspartate (NMDA)IBA
11/2020 - 07/2017
2Cyclic NucleotidesIBA
11/2020 - 07/2016
2Antidepressive Agents (Antidepressants)IBA
01/2019 - 08/2012
2Donepezil (Aricept)FDA LinkGeneric
01/2019 - 04/2015
2Pilocarpine (Ocusert)FDA LinkGeneric
01/2019 - 01/2013
2Galantamine (Galanthamine)FDA LinkGeneric
01/2019 - 04/2015
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2018 - 11/2016
2Phenobarbital (Luminal)FDA Link
06/2018 - 01/2018
2Carbamazepine (Tegretol)FDA LinkGeneric
06/2018 - 08/2012
2Diazepam (Valium)FDA LinkGeneric
06/2018 - 02/2011
2Glycine (Aminoacetic Acid)FDA LinkGeneric
07/2017 - 04/2003
2RitanserinIBA
06/2017 - 04/2015
2Ondansetron (Zofran)FDA LinkGeneric
06/2017 - 02/2011
2methyllycaconitineIBA
01/2017 - 11/2016
2Fluoxetine (Prozac)FDA LinkGeneric
10/2013 - 08/2012
25-HT1A Serotonin ReceptorIBA
02/2013 - 07/2008
2Lurasidone HydrochlorideFDA Link
07/2010 - 10/2007
2tandospironeIBA
04/2009 - 07/2008
2SaltsIBA
04/2007 - 12/2006
2Acetates (Acetic Acid Esters)FDA Link
04/2007 - 12/2006
2Desoxycorticosterone Acetate (DOCA)FDA Link
04/2007 - 12/2006
2Desoxycorticosterone (Deoxycorticosterone)IBA
04/2007 - 12/2006
1Glutamic Acid (Glutamate)FDA Link
07/2023
1SCH 23390IBA
01/2022
1Dopamine Receptors (Dopamine Receptor)IBA
01/2022
1Dopamine (Intropin)FDA LinkGeneric
01/2022
12,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
01/2022
1Cell Adhesion MoleculesIBA
11/2020
1Amino AcidsFDA Link
11/2020
1NucleotidesIBA
11/2020
1AcidsIBA
11/2020
1phosphonic acidIBA
11/2020
1Ionotropic Glutamate ReceptorsIBA
11/2020
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2020
1Excitatory Amino Acid AntagonistsIBA
11/2020
1LY 341495IBA
11/2020
12,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA
11/2020
1piperidineIBA
11/2020
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2019
1Paraoxon (E600)IBA
04/2019
1OrganophosphatesIBA
04/2019
1Cholinesterases (Cholinesterase)IBA
04/2019
1PotassiumIBA
02/2019
1Transcription Activator-Like EffectorsIBA
01/2019
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2019

Therapy/Procedure

2Therapeutics
01/2013 - 08/2012